Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Is this your company? Claim this profile
Drug Product
Company Overview
About
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:China
Founded:2019
Employees:1,562
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval 6F9ARF
EMA · #APR-CAKA4SZY · 2020-12-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-PTYEB4UK
Issued: 2020-11-08
Expires: 2025-08-21
Health Canada GMP
Health Canada
Cert #: CERT-Z32GYUV9
Issued: 2020-07-11
Expires: 2025-04-12
Loading CDMO intelligence...
Key facts about Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
- Hubei Hongyuan Pharmaceutical Technology Co., Ltd. is headquartered in China.
- Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2019.
- Hubei Hongyuan Pharmaceutical Technology Co., Ltd. has 1,562 employees.
- Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Directory pages this company appears in, each with the full list of matching manufacturers.